Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T13:41:48.855Z.
Calculation as of: 2026-10-06T13:41:48.855Z.
Quote observation: 2026-10-06T13:40:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4980e4284b6230c79d3dcd5f09fe919c7c05eb80d65ab6e095ba480293e97312
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Canton Strategic Holdings Inc
Market Cap
$178.54M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.71M
EV/FCF Ratio
N/A
TTM Avg
72.04x
3Y Avg
55.57x
5Y Avg
55.57x
Market Cap
$173.34M
EV/FCF Ratio
N/A
TTM Avg
277.79x
3Y Avg
277.79x
5Y Avg
277.79x
Market Cap
$169.95M
EV/FCF Ratio
N/A
TTM Avg
568.17x
3Y Avg
568.17x
5Y Avg
88.75x
Market Cap
$193.74M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canton Strategic Holdings Inc (CNTN) | $178.54M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $177.29M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $183.71M | N/A | 72.04x | 55.57x | 55.57x |
| Precision BioSciences, Inc. (DTIL)vs › | $173.34M | N/A | 277.79x | 277.79x | 277.79x |
| Coherus Oncology, Inc. (CHRS)vs › | $169.95M | N/A | 568.17x | 568.17x | 88.75x |
| Compass Therapeutics, Inc. (CMPX)vs › | $171.61M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $193.74M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $194.49M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $161.63M | N/A | 55.26x | 38.45x | 50.33x |
| ALX Oncology Holdings Inc. (ALXO)vs › | $158.25M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
